{"nct_id":"NCT03963232","title":"A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2019-07-30","start_date_type":"ACTUAL","primary_completion_date":"2021-07-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}